Jan Balzarini

645 total citations
10 papers, 555 citations indexed

About

Jan Balzarini is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Jan Balzarini has authored 10 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Virology and 3 papers in Organic Chemistry. Recurrent topics in Jan Balzarini's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers) and Biochemical and Molecular Research (2 papers). Jan Balzarini is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers) and Biochemical and Molecular Research (2 papers). Jan Balzarini collaborates with scholars based in Belgium, United Kingdom and Italy. Jan Balzarini's co-authors include Erik De Clercq, Lieve Naesens, Christopher McGuigan, Huub Schellekens, Henk Niphuis, Ivan Rosenberg, Carlo Ballatore, J. Kruining, Carlo Federico Perno and Stefano Aquaro and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Jan Balzarini

10 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Balzarini Belgium 8 372 231 202 168 155 10 555
H. TANAKA Japan 10 601 1.6× 482 2.1× 168 0.8× 185 1.1× 188 1.2× 32 753
T. MIYASAKA Japan 10 364 1.0× 278 1.2× 220 1.1× 117 0.7× 167 1.1× 25 572
Lisa Zadjura United States 9 332 0.9× 307 1.3× 94 0.5× 109 0.6× 156 1.0× 9 567
T K Sawyer United States 9 410 1.1× 388 1.7× 178 0.9× 63 0.4× 89 0.6× 9 583
Anne V. Broadhurst United Kingdom 6 591 1.6× 514 2.2× 302 1.5× 102 0.6× 216 1.4× 8 855
T. J. MCQUADE United States 5 388 1.0× 360 1.6× 184 0.9× 55 0.3× 78 0.5× 5 539
Christopher T. Lemke Canada 15 287 0.8× 276 1.2× 291 1.4× 58 0.3× 112 0.7× 27 647
S. Benzaria France 11 370 1.0× 111 0.5× 335 1.7× 183 1.1× 139 0.9× 25 638
Motohide Sato Japan 7 511 1.4× 441 1.9× 306 1.5× 99 0.6× 174 1.1× 12 736
Imma Clotet‐Codina Spain 15 270 0.7× 271 1.2× 147 0.7× 107 0.6× 234 1.5× 21 539

Countries citing papers authored by Jan Balzarini

Since Specialization
Citations

This map shows the geographic impact of Jan Balzarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Balzarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Balzarini more than expected).

Fields of papers citing papers by Jan Balzarini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Balzarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Balzarini. The network helps show where Jan Balzarini may publish in the future.

Co-authorship network of co-authors of Jan Balzarini

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Balzarini. A scholar is included among the top collaborators of Jan Balzarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Balzarini. Jan Balzarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Allouchi, H., Abdelhak Kherbeche, Jean‐Claude Debouzy, et al.. (2001). Synthesis of 3-Nitrosoimidazo[1,2-a]pyridine Derivatives as Potential Antiretroviral Agents. Archiv der Pharmazie. 334(7). 224–228. 18 indexed citations
3.
Ballatore, Carlo, Christopher McGuigan, Erik De Clercq, & Jan Balzarini. (2001). Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA. Bioorganic & Medicinal Chemistry Letters. 11(8). 1053–1056. 52 indexed citations
4.
Balzarini, Jan, Stefano Aquaro, Chiara Rampazzo, et al.. (2000). Cyclosaligenyl-2′,3′-didehydro-2′,3′-dideoxythymidine Monophosphate: Efficient Intracellular Delivery of d4TMP. Molecular Pharmacology. 58(5). 928–935. 45 indexed citations
5.
Balzarini, Jan, Stefano Aquaro, Chiara Rampazzo, et al.. (2000). Cyclosaligenyl-2′,3′-didehydro-2′,3′-dideoxythymidine Monophosphate: Efficient Intracellular Delivery of d4TMP. Molecular Pharmacology. 58(5). 928–935. 3 indexed citations
6.
McGuigan, Christopher, et al.. (1998). Lactate cannot substitute for alanine in D4T-based anti-HIV nucleotide prodrugs-despite efficient esterase-mediated hydrolysis. Bioorganic & Medicinal Chemistry Letters. 8(21). 2949–2954. 7 indexed citations
7.
8.
Balzarini, Jan, J. Kruining, Heidi Pelemans, et al.. (1996). Anti-HIV and Anti-HBV Activity and Resistance Profile of 2′,3′-Dideoxy-3′-Thiacytidine (3TC) and Its Arylphosphoramidate Derivative CF 1109. Biochemical and Biophysical Research Communications. 225(2). 363–369. 50 indexed citations
9.
Balzarini, Jan, Lieve Naesens, Henk Niphuis, et al.. (1991). 9-(2-phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys. AIDS. 5(1). 21–28. 194 indexed citations
10.
Tanaka, Hiromichi, Masanori Baba, Hiroyuki Hayakawa, et al.. (1991). A new class of HIV-1 specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Journal of Medicinal Chemistry. 34(1). 349–357. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. TANAKA Breakdown of academic impact, for papers by T. MIYASAKA Breakdown of academic impact, for papers by Lisa Zadjura Breakdown of academic impact, for papers by T K Sawyer Breakdown of academic impact, for papers by Anne V. Broadhurst Breakdown of academic impact, for papers by T. J. MCQUADE Breakdown of academic impact, for papers by Christopher T. Lemke Breakdown of academic impact, for papers by S. Benzaria Breakdown of academic impact, for papers by Motohide Sato Breakdown of academic impact, for papers by Imma Clotet‐Codina
Rankless by CCL
2026